- +123.2% price growth over the last year
- High gross margin of 100.0%
- Lower volatility than the market (beta -0.21)
Green day on Friday for Connect Biopharma Holdings Ltd American stock after gaining 0.95%
(Updated on Jun 12, 2026)
The Connect Biopharma Holdings Ltd American stock price gained 0.95% on the last trading day (Friday, 12th Jun 2026), rising from $2.10 to $2.12. During the last trading day the stock fluctuated 5.07% from a day low at $2.07 to a day high of $2.18. The price has been going up and down for this period, and there has been a -14.86% loss for the last 2 weeks. Volume fell on the last day by -173 thousand shares and in total, 172 thousand shares were bought and sold for approximately $364.44 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.05 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -23.77% during the next 3 months and, with a 90% probability hold a price between $1.56 and $2.22 at the end of this 3-month period.
CNTB Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 1.92%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Connect Biopharma Holdings Ltd American stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.16 and $2.35. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Connect Biopharma Holdings Ltd American stock
Connect Biopharma Holdings Ltd American finds support from accumulated volume at $2.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.105 between high and low, or 5.07%. For the last week the stock has had daily average volatility of 6.65%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CNTB) For The Upcoming Trading Day Of Monday 15th
For the upcoming trading day on Monday, 15th we expect Connect Biopharma Holdings Limited American Depositary Shares to open at $2.12, and during the day (based on 14 day Average True Range), to move between $2.03 and $2.21, which gives a possible trading interval of +/-$0.183 (+/-9.00%) up or down from last closing price. If Connect Biopharma Holdings Limited American Depositary Shares takes out the full calculated possible swing range there will be an estimated 9.00% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.10 (0.94%) than the resistance at $2.40 (13.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Connect Biopharma Holdings Limited American Depositary Shares stock A Buy?
Connect Biopharma Holdings Ltd American holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-2.850
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 15, 2026 - $2.12 ( 0.0786%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CNTB Performance
Trading levels for CNTB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.23 | 5.03% |
| R2 | 2.19 | 3.14% |
| R1 | 2.16 | 1.97% |
| Price | 2.12 | |
| S1 | 2.08 | -1.81% |
| S2 | 2.06 | -2.98% |
| S3 | 2.02 | -4.87% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.63 | 24.06% |
| R2 | 2.58 | 21.70% |
| R1 | 2.40 | 13.21% |
| Price | 2.12 | |
| S1 | 2.10 | -0.94% |
| S2 | 2.08 | -1.89% |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Connect Biopharma Holdings Limited American Depositary Shares Stock.
Buy CNTB